Crossmark

Tranexamic Acid for reduction of intra- and postoperative TRansfusion requirements in elective Abdominal surgery (TATRA): study protocol for an investigator-initiated, multicenter, double-blind, placebo-controlled, randomized superiority trial with two parallel groups

Crossref DOI link: https://doi.org/10.1186/s13063-024-08541-8

Published Online: 2024-10-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ronellenfitsch, Ulrich https://orcid.org/0000-0003-1107-813X
Kestel, Anita

Klose, Johannes

Rebelo, Artur

Bucher, Michael

Ebert, Daniel

Mikolajczyk, Rafael

Wienke, Andreas

Kegel, Thomas

Hering, Julian

Haiduk, Christian

Richter, Michael

Steighardt, Jörg

Grohmann, Erich

Otto, Lutz

Kleeff, Jörg
Funding

Funding for this research was provided by:

Universitätsklinikum Halle (Saale)
License Information

Text and Data Mining valid from 2024-10-19

Version of Record valid from 2024-10-19
More Information

Article History

Received: 8 July 2024

Accepted: 8 October 2024

First Online: 19 October 2024

Declarations

:

: German Federal Institute for Drugs and Medical Devices 10.3–2023-509970–43-01-B-01461. EU Trial (CTIS) Number 2023–509970-43–01. Written, informed consent to participate will be obtained from all participants.

: Not applicable, no details, images, or videos relating to an individual person are published.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below